Proprostate-specific antigen: Its usefulness in the era of multiple-core prostate biopsy

International Journal of Urology

Volumn 16, Issue 6, 2009, Pages 561-565

  Miyakubo, Mai ^a   Ito, Kazuto ^a   Yamamoto, Takumi ^a   Takechi, Hiroyuki ^a   Ohi, Masaru ^a   Suzuki, Kazuhiro ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Free PSA; ProPSA; Prostate cancer; Prostate specific antigen (PSA); Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 66949121100     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02304.x     Document Type: Article

References (18)

1. Catalona WJ, Smith DS, Ratliff TL et al. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991 324 : 1156 61.
2. Labrie F, Dupont A, Suburu R et al. Serum prostate specific antigen as pre-screening test for prostate cancer. J. Urol. 1992 147 : 846 51.
3. Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Result of a multicenter trial of 6,630 men. J. Urol. 1994 151 : 1283 90.
4. Catalona WJ, Smith DS, Wolfert RL et al. Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening. JAMA 1995 274 : 1214 20.
5. Prestigiacomo AF, Lilja H, Pettersson K et al. A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: The best case scenario. J. Urol. 1996 156 : 350 4.
6. Partin AW, Catalona WJ, Southwick PC et al. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume and age. Urology 1996 48 : 55 61. (Pubitemid 26425537)
7. Kikuchi E, Nakashima J, Ishibashi M et al. Prostate specific antigen adjusted for transition zone volume: The most powerful method for detecting prostate carcinoma. Cancer 2000 89 : 842 9.
8. Bangma CH, Wildhagen MF, Yurdakul G et al. The value of (-7,-5) pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer. BJU Int. 2004 93 : 720 4.
9. Kumar A, Mikolajczyk SD, Goel AS et al. Expression of pro form of prostate specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res. 1997 57 : 3111 14.
10. Ito K, Ohi M, Yamamoto T et al. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL. Cancer 2002 95 : 2112 19.
11. Jiang Y, Metz CE, Nishikawa RH. A receiver operating characteristic partial area index for highly sensitive diagnostic tests. Radiology 1996 201 : 745 50.
12. Gjengsto P, Paus E, Halvorsen OJ et al. Predictors of prostate cancer evaluated by receiver operating characteristics partial area index: A prospective institutional study. J. Urol. 2005 173 : 425 8.
13. Epstein JI, Allsbrook WC, Amin MB et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 2005 29 : 1228 42.
14. Khan MA, Partin AW, Rittenhouse HG et al. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/mL. J. Urol. 2003 170 : 723 6.
15. Sokoll LJ, Chan DW, Mikolajczyk SD et al. Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/mL total psa range: Preliminary analysis. Urology 2003 61 : 274 6.
16. Khan MA, Sokoll LJ, Chan DW et al. Clinical utility of proPSA and 'benign' PSA when percent free PSA is less than 15 Urology 2004 64 : 1160 4.
17. Catalona WJ, Bartsch G, Rittenhouse HG et al. Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/mL prostate specific antigen. J. Urol. 2004 171 : 2239 44.
18. Stephan C, Meyer HA, Paul EM et al. Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer. Anticancer Res. 2007 27 : 1833 6.